Osteosarcoma and Ewing's sarcoma in children and adolescents: Retrospective clinicopathological study

Croatian Medical Journal

Volumn 45, Issue 6, 2004, Pages 740-745

  Ilić, Ivana ^a   Manojlović, Spomenka ^a   Ćepulić, Mladen ^b   Orlić, Dubravko ^a   Seiwerth, Sven ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b Croatia   (Croatia)

Author keywords

Adolescent; Bone neoplasms; Child; Osteosarcoma; Sarcoma, Ewing's

Indexed keywords

LACTATE DEHYDROGENASE;

ADOLESCENT; ARTICLE; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; CELL DIFFERENTIATION; CHILD; CLINICAL FEATURE; ERYTHROCYTE SEDIMENTATION RATE; EWING SARCOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METASTASIS; OSTEOSARCOMA; PROGNOSIS; SURVIVAL TIME;

ADOLESCENT; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; CROATIA; FEMALE; HUMANS; INFANT; MALE; OSTEOSARCOMA; PROGNOSIS; RETROSPECTIVE STUDIES; SARCOMA, EWING'S; SURVIVAL RATE;

EID: 11144222599     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Finegold M. Bone tumors. In: Finegold M: Pathology of neoplasia in children and adolescents. 2nd ed. Philadelphia: WB Saunders Company; 1986. p 256-280.
2. Parkin DM, Stiller CA, Nectoux J. International variations in the incidence of childhood bone tumors. Int J Cancer. 1993;53:371-6.
3. McWhirter WR, Dobson C, Ring I. Childhood cancer incidence in Australia, 1982-1991. Int J Cancer. 1996; 65:34-8.
4. McWhirter WR, Petroeschevsky AL. Childhood cancer incidence in Queensland, 1979-88. Int J Cancer. 1990;45:1002-5.
5. La Quaglia MP, Osteosarcoma. Specific tumor management and results. Chest Surg Clin N Am. 1998;8:77-95.
6. Glasser DB, Lane JM, Huvos AG, Marcove RC, Rosen G. Survival, prognosis, and therapeutic response in osteogenic sarcoma. The Memorial Hospital experience. Cancer. 1992;69:698-708.
7. Wunder JS, Paulian G, Huvos AG, Heller G, Meyers PA, Healey JH. The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma. J Bone Joint Surg Am. 1998;80:1020-33.
8. Davis AM, Bell RS, Goodwin PJ. Prognostic factors in osteosarcoma: a critical review. J Clin Oncol. 1994;12: 423-31.
9. Dunst J, Jurgens H, Sauer R, Pape H, Paulussen M, Winkelmann W, et al. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial. Int J Radiat Oncol Biol Phys. 1995;32:919-30.
10. Cotterill SJ, Ahrens S, Paulussen M, Jurgens HF, Voute PA, Gadner H, et al. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol. 2000;18:3108-14.
11. Bacci G, Ferrari S, Bertoni F, Rimondini S, Longhi A, Bacchini P, et al. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. J Clin Oncol. 2000;18:4-11.
12. Kawai A, Huvos AG, Meyers PA, Healey JH. Osteosarcoma of the pelvis. Oncologic results of 40 patients. Clin Orthop. 1998 (348):196-207.
13. Spanier SS, Shuster JJ, Vander Griend RA. The effect of local extent of the tumor on prognosis in osteosarcoma. J Bone Joint Surg Am. 1990;72:643-53.
14. Brostrom LA, Strander H, Nilsonne U. Survival in osteosarcoma in relation to tumor size and location. Clin Orthop. 1982 (167):250-4.
15. Ferrari S, Bertoni F, Mercuri M, Picci P, Giacomini S, Longhi A, et al. Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute. Ann Oncol. 2001;12:1145-50.
16. Bacci G, Longhi A, Ferrari S, Lari S, Manfrini M, Donati D, et al. Prognostic significance of serum alkaline phosphatase in osteosarcoma of the extremity treated with neoadjuvant chemotherapy: recent experience at Rizzoli Institute. Oncol Rep. 2002;9:171-5.
17. Pochanugool L, Subhadharaphandou T, Dhanachai M, Hathirat P, Sangthawan D, Pirabul R, et al. Prognostic factors among 130 patients with osteosarcoma. Clin Orthop. 1997 (345):206-14.
18. Bacci G, Ferrari S, Rosito P, Avella M, Barbieri E, Picci P, et al. Ewing's sarcoma of the bone. Anatomoclinical study of 424 cases [in Italian]. Minerva Pediatr. 1992; 44:345-59.
19. Brostrom LA, Ingimarsson S, Strander H, Eklund G. Correlation between prognostic factors and blood variables in osteosarcoma. Acta Med Scand. 1980;207:429-31.
20. De Alava E, Antonescu CR, Panizo A, Leung D, Meyers PA, Huvos AG, et al. Prognostic impact of P53 status in Ewing sarcoma. Cancer. 2000;89:783-92.
21. Bauer HC, Kreicbergs A, Silfversward C. Prognostication including DNA analysis in osteosarcoma. Acta Orthop Scand. 1989;60:353-60.
22. Gorlick R, Huvos AG, Heller G, Aledo A, Beardsley GP, Healey JH, et al. Expression of HER2/erbB-2 correlates with survival in osteosarcoma. J Clin Oncol. 1999;17: 2781-8.
23. Kuryu M, Ozaki T, Nishida K, Shibahara M, Kawai A, Inoue H. Expression of CD44 variants in osteosarcoma. J Cancer Res Clin Oncol. 1999;125:646-52.
24. Wunder JS, Bull SB, Aneliunas V, Lee PD, Davis AM, Beauchamp CP, et al. MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study. J Clin Oncol. 2000;18:2685-94.
25. Feugeas O, Guriec N, Babin-Boilletot A, Marcellin L, Simon P Babin S, et al. Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma. J Clin Oncol. 1996;14:467-72.
26. Raymond AK, Chawla SP, Carrasco CH, Ayala AG, Fanning CV, Grice B, et al. Osteosarcoma chemotherapy effect: a prognostic factor. Semin Diagn Pathol. 1987; 4:212-36.
27. Delepine N, Delepine G, Cornille H, Voisin MC, Brun B, Desbois JC. Prognostic factors in patients with localized Ewing's sarcoma: the effect on survival of actual received drug dose intensity and of histologic response to induction therapy. J Chemother. 1997;9:352-63.
28. Kinsella TJ, Miser JS, Waller B, Venzon D, Glatstein E, Weaver-McClure L, et al. Long-term follow-up of Ewing's sarcoma of bone treated with combined modality therapy. Int J Radiat Oncol Biol Phys. 1991;20:389-95.
29. Wolf RE, Enneking WF. The staging and surgery of musculoskeletal neoplasms. Orthop Clin North Am. 1996;27:473-81.
30. Huvos AG, Rosen G, Marcove RC. Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med. 1977; 101:14-8.
31. Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer. 1982;49:1221-30.